Skip to content

Other at other companies

Devon Energy logo
Devon EnergyDVN
0%
American International Group logo
American International GroupAIG
0.5%+0.2pp
IBEX Limited logo
IBEX LimitedIBEX
0.2%-0.8pp
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-0.1%0.0pp
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
-0.3%-1.2pp
General Motors logo
General MotorsGM
-$4.5M

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther.

The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's other?
Opus Genetics (IRD) reported other of -$0 in Q4 2025.
How has Opus Genetics's other changed year-over-year?
Opus Genetics's other decreased by 166.7% year-over-year, from $0 to -$0.
What is the long-term trend for Opus Genetics's other?
Over 4 years (2021 to 2025), Opus Genetics's other has grown at a 41.4% compound annual growth rate (CAGR), from -$0 to -$0.01.